1-8 of 8
Lorenz Jahn
Close
Sort by
Journal Articles

Recirculating Regulatory T Cells Mediate Thymic Regeneration in a ZFP36L1 and Amphiregulin Dependent Manner

Andri Leo L Lemarquis, Anastasia Kousa, Kimon V Argyropoulos, Lorenz Jahn, Brianna Gipson, Lucia Serrano-Marin, Hana Andrlova, Jennifer Tsai, Jarrod A Dudakov, Susan DeWolf, Marcel R.M. van den Brink
Journal: Blood
Blood (2023) 142 (Supplement 1): 457.
https://doi.org/10.1182/blood-2023-183036
Published: 2023
Journal Articles

The Damage Sensory Molecule TRPA1 Positively Regulates Endogenous Thymic Regeneration after Damage

Kimon Argyropoulos, MD, Enrico Velardi, PhD BS, Jennifer Tsai, MD PhD, Amina Lazrak, BS, Lorenz Jahn, PhD, Jarrod A Dudakov, PhD, Marcel R.M. van den Brink, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 67.
https://doi.org/10.1182/blood.V130.Suppl_1.67.67
Published: 2017
Journal Articles

TCR-based therapy for multiple myeloma and other B-cell malignancies targeting intracellular transcription factor BOB1

Lorenz Jahn, Pleun Hombrink, Renate S. Hagedoorn, Michel G. D. Kester, Dirk M. van der Steen, Tania Rodriguez, Tsvetelina Pentcheva-Hoang, Arnoud H. de Ru, Marjolein P. Schoonakker, Miranda H. Meeuwsen, Marieke Griffioen, Peter A. van Veelen, J. H. Frederik Falkenburg, Mirjam H. M. Heemskerk
Journal: Blood
Blood (2017) 129 (10): 1284–1295.
https://doi.org/10.1182/blood-2016-09-737536
Published: 2017
Includes: Supplemental data
Journal Articles

Inducible MyD88/CD40 (iMC) Enhances Proliferation and Survival of Tumor-Specific TCR-Modified T Cells and Improves Anti-Tumor Efficacy in Myeloma

Tsvetelina Pentcheva-Hoang, PhD, David Torres, Tania Rodriguez, PhD, Ana Korngold, PhD, An Lu, Jeannette Crisostomo, Annemarie Moseley, MD PhD, Lorenz Jahn, Mirjam H.M. Heemskerk, PhD, Kevin M Slawin, MD, David M Spencer, PhD, Aaron E Foster, PhD
Journal: Blood
Blood (2016) 128 (22): 4550.
https://doi.org/10.1182/blood.V128.22.4550.4550
Published: 2016
Journal Articles

T Cell Receptor Gene Therapy Targeting the Intracellular Transcription Factor Bob1 for the Treatment of Multiple Myeloma and Other B Cell Malignancies

Lorenz Jahn, Renate S. Hagedoorn, Pleun Hombrink, PhD, Michel G.D. Kester, Dirk M. van der Steen, Chopie Hassan, Marjolein P. Schoonakker, Erwin van der Pijl, Peter A. van Veelen, PhD, J.H. Frederik Falkenburg, MD PhD, Mirjam H.M. Heemskerk, PhD
Journal: Blood
Blood (2015) 126 (23): 3002.
https://doi.org/10.1182/blood.V126.23.3002.3002
Published: 2015
Journal Articles

Therapeutic targeting of the BCR-associated protein CD79b in a TCR-based approach is hampered by aberrant expression of CD79b

Lorenz Jahn, Pleun Hombrink, Chopie Hassan, Michel G. D. Kester, Dirk M. van der Steen, Renate S. Hagedoorn, J. H. Frederik Falkenburg, Peter A. van Veelen, Mirjam H. M. Heemskerk
Journal: Blood
Blood (2015) 125 (6): 949–958.
https://doi.org/10.1182/blood-2014-07-587840
Published: 2015
Includes: Supplemental data
Journal Articles

T Cell Receptors Specific for the Intracellular Transcription Factor Bob1 Allow Efficient Targeting of Human B Cell Leukemia and Multiple Myeloma

Lorenz Jahn, Pleun Hombrink, Michel G.D. Kester, Dirk M. van der Steen, Renate S. Hagedoorn, Chopie Hassan, Marjolein P. Schoonakker, Erwin van der Pijl, Peter A. van Veelen, PhD, J.H. Frederik Falkenburg, MD PhD, Mirjam H.M. Heemskerk, PhD
Journal: Blood
Blood (2014) 124 (21): 3832.
https://doi.org/10.1182/blood.V124.21.3832.3832
Published: 2014
Journal Articles

High-Affinity CD20-Specific T-Cell Receptors Suitable for Adoptive Immunotherapy in the Treatment of CD20 low B-Cell Malignancies

Lorenz Jahn, Pleun Hombrink, Chopie Hassan, Michel G.D. Kester, Renate S. Hagedoorn, Dirk M. van der Steen, Marjolein P. Schoonakker, J.H. Frederik Falkenburg, MD PhD, Peter A. van Veelen, PhD, Mirjam H.M. Heemskerk, PhD
Journal: Blood
Blood (2014) 124 (21): 3837.
https://doi.org/10.1182/blood.V124.21.3837.3837
Published: 2014